X0508 4 2023-12-05 false 0001314102 EyePoint Pharmaceuticals, Inc. EYPT 0001840407 Liu Ye 56F, ONE MUSEUM PLACE, 669 XIN ZHA ROAD JING'AN DISTRICT SHANGHAI 200041 true false false false false Common Stock, $0.001 par value 2023-12-05 4 S false 733758.00 19.91 D 2276963.00 I Ocumension Therapeutics Common Stock, $0.001 par value 2023-12-06 4 S false 266242.00 18.41 D 2010721.00 I Ocumension Therapeutics The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.80 to $20.38. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The shares are held by Ocumension Therapeutics. The reporting person is Chief Executive Officer and a Director of Ocumension Therapeutics. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.17 to $18.49. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Ron Honig, Attorney-in-Fact 2023-12-07